VVigilance Weekly공개 리포트 보기
← 이번 주 리포트
tofacitinib우선순위 낮음근거 검토기타

LITERATURE DETAIL · PMID 42508508

Deciphering in vitro-in vivo correlation of single-dose injectable sustained-release tofacitinib-loaded microspheres for long-acting anti-inflammatory therapy of rheumatoid arthritis.

Deciphering in vitro-in vivo correlation of single-dose injectable sustained-release tofacitinib-loaded microspheres for long-acting anti-inflammatory therapy of rheumatoid arthritis.

저자
Xin-Hong Wu, Le-Yan Gu, Ye-Chao Zhang, Jing-Yi Liu, Yan-Kai Qu, Cai-Yi Ping
저널
International journal of pharmaceutics
공개일
2026 Jul 27
연구 유형
기타
DOI
10.1016/j.ijpharm.2026.127239

문헌 요약

Tofacitinib is a potent Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA); however, its clinical application is limited by inherent side effects, a short half-life, and the requirement for frequent dosing. In this study, poly(lactic-co-glycolic acid) (PLGA)-based injectable sustained-release tofacitinib microspheres with distinct in vi…

PV 검토 포인트

누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.

PubMed에서 원문 정보 보기